期刊文献+

冠状动脉内血栓抽吸物炎症机制的研究进展 被引量:2

Research progress about inflammatory mechanism of aspirated thrombus from coronary artery
下载PDF
导出
摘要 血栓抽吸导管可于置入支架前预抽吸血栓,可显著减少ST段抬高型心肌梗死患者经皮冠状动脉介入术后无复流、慢血流的发生率,改善患者预后。同时,对冠状动脉内血栓抽吸所获样本进行病理分析,也为深入研究ST段抬高型心肌梗死的病理生理过程提供了新途径。随着对冠状动脉内血栓抽吸物研究的不断深入,发现炎症反应起着重要作用,本文就冠状动脉内血栓抽吸物的局部炎症浸润、全身炎症活动及其对预后的影响予以综述。 Thrombus aspiration catheter was used for pre-suction before stent implantation in ST segment elevation myocardial infarction ( STEMI ) patents. The incidence of no reflow and slow flow has obviously decreased in this condition. At the same time,the pathological analysis of coronary thrombus also provides a new idea for the further study of pathophysiology of STEMI. After advanced studies of aspirated thrombus from coronary artery, inflammatory response is found to play an important role. This review is to explicate the local inflammatory response,systemic response and prognosis of aspirated thrombus.
作者 孙希鹏 华琦
出处 《中国心血管杂志》 2016年第4期324-326,共3页 Chinese Journal of Cardiovascular Medicine
关键词 炎症 心肌梗死 冠状动脉血栓形成 Inflammation Myocardial infarction Coronary thrombosis
  • 相关文献

参考文献19

  • 1Vlaar PJ, Svilaas T, van der Horst IC, et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Pereutaneous coronary intervention in Acute myocardial infarction Study ( TAPAS ) : a 1 -year follow-up study [ J ]. Lancet, 2008,371 (9628) :1915-1920. DOI:10. 1016/S0140-6736(08)60833-8.
  • 2赵树武,马洪俊,王媛媛,王玉平,吴英凤,刘长红,王玉昆,刘革明,桂正光,李振龙,曹景丽,张杰,刘毅,许承斌,李玉花.急性冠状动脉综合征患者经皮冠状动脉介入治疗成形术中血栓抽吸对术后1年心脏事件的影响[J].中国心血管杂志,2013,18(1):9-11. 被引量:9
  • 3李怀东,曾惠,骆丽,张立新,郭金成.急性心肌梗死患者冠状动脉内抽吸物成分与再灌注水平的关系[J].中国心血管杂志,2014,19(4):269-272. 被引量:5
  • 4Inoue T,Kato T, Uehida T, et ah Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting[ J ]. J Am Coil Cardio1,2005,46 ( 2 ) :239-245.
  • 5Ko YG,Jung JH,Park S,et al. Inflammatory and vasoactive factors in the aspirate from the culprit coronary artery of patients with acute myocardial infraction [ J ] . Int J Cardiol, 2006, 112 ( 1 ) : 66-71.
  • 6Aggarwal A,Schneider DJ, Terrien EF, et al. Increased coronary arterial release of interleukin-I receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques[ J]. Am J Cardio1,2004,93 ( 1 ) :6-9.
  • 7Maier W,Attwegg LA, Corti R, et al. Inflammatory markers at the site of ruptured plaque in acute myocardiai infarction: locally increased interleukin-6 and serum amyloid A but decreased C- reactive protein[ J]. Circulation ,2005,111 ( 11 ) : 1355-1361.
  • 8Kolodgie FD, Burke AP, Skorija KS, et al. Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis [ J ] . Arterioscler Thromb Vasc Biol,2006,26( 11 ) :2523-2529.
  • 9Li N,Li S, Yu C, et al. Plasma Lp-PLA2 in acute coronary syndrome: association with major adverse cardiac events in a community-based cohort[ J ]. Postgrad Med, 2010, 122 (4) : 200- 205. DOI : 10.3810/pgm. 2010.07.2187.
  • 10Liu YS, Hu XB, Li HZ ,et al. Association of lipoprotein-assoeiated phospholipase A2 with characteristics of vulnerable eoronary atherosclerotic plaques [ J ] . Yonsei Med J, 2011 , 52 ( 6 ) : 914- 922. DOI: 10. 3349/ymj. 2011.52.6.914.

二级参考文献20

  • 1毛节明,王广.动脉粥样硬化与炎症[J].中国循环杂志,2006,21(6):405-406. 被引量:20
  • 2Libby P, Okamoto Y, Rocha VZ, et al. Inflammation in atherosclerosis : transition from theory to practice. C irc J,2010,74 (2) :213-220.
  • 3Maier W, Ahwegg LA, Corti R, et al. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction : locally increased in- terleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation ,2005,111 ( 11 ) : 1355-1361.
  • 4Jafie R,Charron T, Puley G, et al. Microvascular obstructim and the no-reflow phenomenon alter percntancous coronary intervention. Circulation, 200g, 117: 3152-3156.
  • 5Schwartz BG, Kloner RA. Coronary no retlow. J Mol Cell Cardiol, 2012, 52: 873-882.
  • 6Niccoli G,Burzotta F, Galiuto L, et al. Myocardial no-retlow in humans. J Am Coil Cardiol, 2009, 54 : 281-292.
  • 7Ndrepepa G,Tiroeh K, Fusaro M, et al. 5-year prognostic valne of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coil Cardiol, 2010,55 : 2383-2389.
  • 8Svilaas T,Vlaar PJ, van der Horst IC, et al. Thrombus aspiration during prima' pereutaneous coronary intervention. N Engl J Med, 2008, 358: 557-567.
  • 9Resnic FS, Wainstein M, Lee MK, et al. No-reflow is an independent predictor of death and myocardial intarction after percutaneous coronary intervention. Am Heart J, 2003,145 : 42- 46.
  • 10Sardella G, Mancone M, Canali E, et al. hnpact of thrombectomy with EXPort Catheter in lntht-Related Artery during Primary Percutaneous Coronary Intervention (EXPIRA Trial) on cardiac death. Am J Cardiol, 2010, 106: 624-629.

共引文献21

同被引文献14

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部